إعلان
إعلان

ENVB

ENVB logo

Enveric Biosciences, Inc. Common Stock

4.10
USD
برعاية
-0.05
-1.23%
٠٨ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

4.16

+0.06
+1.49%

تقارير أرباح ENVB

النسبة الإيجابية المفاجئة

ENVB تفوق 11 من 16 آخر التقديرات.

69%

التقرير التالي

بيانات التقرير القادم
٢٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.31
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-99.46%

Enveric Biosciences, Inc. Common Stock earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, ENVB reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.35 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -3.30% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -0.31 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Enveric Biosciences, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved down -3.3%, changed from $5.46 before the earnings release to $5.28 the day after.
The next earning report is scheduled for ٢٦ مارس ٢٠٢٦.
Based on 3 المحللين, Enveric Biosciences, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان